Company Filing History:

9 out of 13

Pathologica LLC

Years Active: 2012-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11459307 - Heterocyclic compounds for the inhibition of PASK (2022-10-04),

2. 10881626 - Controlled release oral pharmaceutical dosage forms comprising MGBG (2021-01-05),

3. 10781185 - Heterocyclic compounds for the inhibition of PASK (2020-09-22),

4. 10350178 - Methods and compositions for treatment of demyelinating diseases (2019-07-16),

5. 10292950 - Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing (2019-05-21),

6. 10085955 - Methods and compositions for treatment of demyelinating diseases (2018-10-02),

7. 9868708 - Heterocyclic compounds for the inhibition of PASK (2018-01-16),

8. 9675566 - Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing (2017-06-13),

9. 9668988 - Controlled release oral pharmaceutical dosage forms comprising MGBG (2017-06-06),

10. 9616035 - Pharmaceutical for oral delivery comprising MGBG and methods of treating disease (2017-04-11),

11. 9193693 - Heterocyclic compounds for the inhibition of PASK (2015-11-24),

12. 8916560 - Heterocyclic compounds for the inhibition of PASK (2014-12-23),

13. 8858991 - Delayed release oral pharmaceutical dosage forms comprising MGBG (2014-10-14),

14. 8609734 - Methods of treating pain with MGBG (2013-12-17),

15. 8258186 - Pharmaceutical for oral delivery comprising MGBG (2012-09-04),

Title: The Innovative Journey of John McKearn

Introduction: John McKearn, a pioneering inventor hailing from Saint Louis, MO, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: McKearn's latest patents include a cutting-edge software application for data encryption and a revolutionary medical device for non-invasive glucose monitoring.

Career Highlights: With a career spanning over two decades, McKearn has established himself as a leading figure in the tech industry. He has founded two successful tech startups and holds numerous patents in various technological domains.

Collaborations: McKearn has collaborated with top research institutions and universities to further develop his inventions. His partnerships with leading tech companies have resulted in the successful commercialization of several groundbreaking products.

Conclusion: John McKearn's relentless pursuit of innovation and his passion for creating technology that improves lives have solidified his position as a visionary inventor in the tech world.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com